Kass calls for ban on cloning after reprogramming advance
former head of the President’s Council on Bioethics, Dr Leon Kass,
says that the validation of reprogramming is an opportunity to pass
long-delayed legislation in the US.
of human somatic cells to pluripotency is an enormously significant
achievement, one that boosters of medical progress and defenders of
human dignity can celebrate without qualification… The ethical and
political benefits may be equally great. The alleged need for
so-called therapeutic cloning — cloning embryos for research — is
now passé. We can therefore disentangle the “life issue”
of embryo-destruction from the “dignity issue” of baby
manufacture, and enact a legislative ban on cloning and other
degrading forms of baby-making, as recommended unanimously by the
President’s Council on Bioethics: Prohibit all attempts to conceive
a child by any means other the union of egg and sperm, both obtained
from adults.” ~ NRO,
- How long can you put off seeing the doctor because of lockdowns? - December 3, 2021
- House of Lords debates assisted suicide—again - October 28, 2021
- Spanish government tries to restrict conscientious objection - October 28, 2021
Mortality rates for American kids are rising for the first time in 50 years
US President Joe Biden is so concerned about the future of American children that he inserted a mandate for affordable...
Will Pope Francis be composted?
Will Pope Francis be composted instead of buried in St Peter’s Basilica in Rome with his predecessors? It’s unlikely. But...
The virtues and the vices of the outrageous
A Norwegian bioethicist, Anna Smajdor, recently set out a case for “Whole Body Gestational Donation” – using the wombs of...
More than 200 people have been treated with experimental CRISPR therapies
Scientists believe that CRISPR gene editing technologies will transform medicine. But how many people have been treated so far? According...
Asia-Pacific IVF market could reach US$46 billion by 2031
According to a market survey by Allied Market Research, IVF is booming in the Asia-Pacific region. The market size was...
Third global summit on human genome editing: Moving on after the He experiment
The much anticipated Third International Summit on Human Genome Editing was held in London earlier this month to explore the...